Polycystic ovary syndrome in obstructive sleep apnea-hypopnea syndrome: an updated meta-analysis.

Jie He, Xia Ruan, Jia Li
Author Information
  1. Jie He: Clinical Medical College of Chengdu Medical College, Chengdu, Sichuan, China.
  2. Xia Ruan: Clinical Medical College of Chengdu Medical College, Chengdu, Sichuan, China.
  3. Jia Li: Clinical Medical College of Chengdu Medical College, Chengdu, Sichuan, China.

Abstract

Background: Obstructive sleep apnea-hypopnea syndrome (OSAHS) is correlated with metabolic deterioration in patients experiencing polycystic ovary syndrome (PCOS). Women diagnosed with PCOS exhibit a heightened prevalence of OSAHS. This meta-analysis aims to assess the morbidity of OSAHS in women affected by PCOS and to examine the differences in metabolism-related indicators between OSAHS-positive and OSAHS-negative in women with PCOS.
Methods: A comprehensive literature analysis of OSAHS morbidity in women with PCOS was conducted, utilizing databases such as CNKI, EMBASE, PubMed, Web of Science, and Wanfang. A comparison was carried out between patients with OSAHS-positive and those with OSAHS-negative in terms of their clinical characteristics and metabolic differences. The search language included English and Chinese. The acquired data were analyzed by employing RevMan 5.2 and Stata 11.0. Continuous variables with the same units were combined and analyzed through weighted mean differences (WMDs) as effect sizes, while continuous variables with different units were combined and analyzed through standardized mean differences (SMDs) as effect sizes. A conjoint analysis was performed on the basis of I value, using either a fixed effect model (I ≤ 50%) or a random effect model (I > 50%).
Results: A total of 21 articles met the inclusion criteria for this study. The findings indicated that 20.8% of women with PCOS were found to have comorbid OSAHS. The subjects were categorized into various subgroups for meta-analysis on the basis of race, age, disease severity, body mass index (BMI), and diagnostic criteria of PCOS. The results revealed high morbidity of OSAHS in all subgroups. In addition, most metabolic indicators and parameters of metabolic syndrome were notably worse in women suffering from both PCOS and OSAHS in comparison to their counterparts solely diagnosed with PCOS.
Conclusion: The current literature indicates higher morbidity of OSAHS among women with PCOS, linking OSAHS with worse metabolic status and obesity in this population. Consequently, clinicians are advised to prioritize the detection and management of OSAHS in women with PCOS.
Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/#myprospero PROSPERO, identifier (CRD42024528264).

Keywords

References

  1. J Clin Endocrinol Metab. 2007 Jul;92(7):2739-43 [PMID: 17488788]
  2. Sleep Med. 2002 Sep;3(5):401-4 [PMID: 14592171]
  3. Sleep Breath. 2012 Dec;16(4):1139-46 [PMID: 22102291]
  4. World J Gastroenterol. 2022 Jun 7;28(21):2320-2333 [PMID: 35800187]
  5. Minerva Endocrinol (Torino). 2022 Apr 07;: [PMID: 35388662]
  6. Sleep Med Rev. 2017 Aug;34:70-81 [PMID: 27568340]
  7. J Clin Sleep Med. 2024 Jan 1;20(1):31-38 [PMID: 37593900]
  8. Iran J Basic Med Sci. 2023;26(6):688-694 [PMID: 37275752]
  9. J Clin Sleep Med. 2024 Jun 1;20(6):871-877 [PMID: 38217476]
  10. J Clin Epidemiol. 2013 Apr;66(4):408-14 [PMID: 23337781]
  11. Obstet Gynecol Surv. 2006 Nov;61(11):723-32 [PMID: 17044949]
  12. Control Clin Trials. 1986 Sep;7(3):177-88 [PMID: 3802833]
  13. Gynecol Endocrinol. 2016 Dec;32(12):1014-1017 [PMID: 27348625]
  14. Sleep. 2018 Jul 1;41(7): [PMID: 29722890]
  15. J Obstet Gynaecol India. 2017 Feb;67(1):61-65 [PMID: 28242970]
  16. Sleep Breath. 2014 Sep;18(3):635-40 [PMID: 24362941]
  17. J Clin Endocrinol Metab. 2016 Apr;101(4):1579-89 [PMID: 26771704]
  18. Nat Sci Sleep. 2018 Feb 01;10:45-64 [PMID: 29440941]
  19. Sci Rep. 2020 Feb 25;10(1):3394 [PMID: 32098974]
  20. Fertil Steril. 2002 Sep;78(3):569-76 [PMID: 12215335]
  21. J Clin Endocrinol Metab. 2006 Aug;91(8):3105-9 [PMID: 16720659]
  22. Indian Dermatol Online J. 2019 Mar-Apr;10(2):97-105 [PMID: 30984582]
  23. Front Endocrinol (Lausanne). 2022 Aug 31;13:922229 [PMID: 36120463]
  24. Biomed Rep. 2018 Nov;9(5):439-445 [PMID: 30402228]
  25. Steroids. 2012 Mar 10;77(4):290-4 [PMID: 22178788]
  26. Semin Reprod Med. 2023 Mar;41(1-02):45-58 [PMID: 38113883]
  27. Breathe (Sheff). 2015 Dec;11(4):297-301 [PMID: 27066123]
  28. Am J Respir Crit Care Med. 2007 Mar 15;175(6):612-7 [PMID: 17341649]
  29. J Clin Endocrinol Metab. 2006 Jan;91(1):36-42 [PMID: 16219719]
  30. Ther Adv Endocrinol Metab. 2020 Feb 21;11:2042018820906689 [PMID: 32128106]
  31. Biomedicines. 2023 Jan 01;11(1): [PMID: 36672616]
  32. Sleep. 2023 Mar 9;46(3): [PMID: 36480010]
  33. Lancet. 2005 Mar 19-25;365(9464):1046-53 [PMID: 15781100]
  34. Hong Kong Med J. 2017 Dec;23(6):622-34 [PMID: 29170361]
  35. J Clin Sleep Med. 2017 Apr 15;13(4):583-589 [PMID: 28162147]
  36. JMIR Form Res. 2022 Mar 15;6(3):e29967 [PMID: 35289757]
  37. Medicine (Baltimore). 2020 Aug 21;99(34):e21591 [PMID: 32846767]
  38. Clin Chest Med. 2021 Sep;42(3):417-425 [PMID: 34353448]
  39. J Clin Endocrinol Metab. 2001 Mar;86(3):1175-80 [PMID: 11238505]
  40. Sleep Breath. 2020 Mar;24(1):339-350 [PMID: 31111411]
  41. Reprod Sci. 2014 Feb 11;21(8):1020-1026 [PMID: 24520086]
  42. Obes Surg. 2021 May;31(5):1986-1993 [PMID: 33423181]
  43. J Am Heart Assoc. 2022 Nov;11(21):e026953 [PMID: 36285783]
  44. Fertil Steril. 2012 Mar;97(3):786-91 [PMID: 22264851]
  45. J Clin Endocrinol Metab. 2001 Feb;86(2):517-20 [PMID: 11158002]
  46. Sleep Breath. 2022 Mar;26(1):497-503 [PMID: 34013438]
  47. Hum Reprod Update. 2011 Jul-Aug;17(4):495-500 [PMID: 21335359]
  48. Respirology. 2017 Jul;22(5):847-848 [PMID: 28417583]
  49. Obesity (Silver Spring). 2013 Aug;21(8):1526-32 [PMID: 23818329]
  50. Endocr J. 2013;60(12):1289-94 [PMID: 24047562]
  51. PLoS One. 2019 Dec 26;14(12):e0226074 [PMID: 31877155]
  52. Cureus. 2022 Jun 25;14(6):e26325 [PMID: 35911341]
  53. Sleep. 2002 Aug 1;25(5):499-506 [PMID: 12150315]
  54. J Clin Endocrinol Metab. 2020 Apr 1;105(4): [PMID: 31901092]
  55. BMC Psychiatry. 2023 May 11;23(1):332 [PMID: 37170227]
  56. J Investig Med. 2014 Aug;62(6):868-74 [PMID: 24844662]
  57. Oncotarget. 2016 Jun 7;7(23):33715-21 [PMID: 27220885]
  58. Hum Reprod Update. 2016 Nov;22(6):687-708 [PMID: 27511809]
  59. J Clin Endocrinol Metab. 2013 Dec;98(12):4565-92 [PMID: 24151290]
  60. J Pediatr Adolesc Gynecol. 2021 Oct;34(5):617-625 [PMID: 33794340]
  61. Medicine (Baltimore). 2016 Dec;95(51):e4863 [PMID: 28002314]
  62. BMJ. 2003 Oct 25;327(7421):951-3 [PMID: 14576245]
  63. Nutrients. 2019 Feb 26;11(3): [PMID: 30813612]
  64. Sleep Med. 2012 Dec;13(10):1307-12 [PMID: 22921588]
  65. Sleep Med. 2014 Dec;15(12):1547-53 [PMID: 25311833]
  66. Sleep Breath. 2018 Dec;22(4):1117-1124 [PMID: 29460195]
  67. Fertil Steril. 2022 May;117(5):924-935 [PMID: 35512976]
  68. Proc Am Thorac Soc. 2008 Feb 15;5(2):136-43 [PMID: 18250205]
  69. Int J Endocrinol Metab. 2014 Jan 05;12(1):e12470 [PMID: 24696694]
  70. J Clin Endocrinol Metab. 2011 Feb;96(2):365-74 [PMID: 21123449]
  71. J Clin Endocrinol Metab. 2008 Oct;93(10):3878-84 [PMID: 18647805]
  72. Expert Rev Respir Med. 2008 Jun 1;2(3):349-364 [PMID: 19690624]
  73. Exp Ther Med. 2016 Mar;11(3):841-845 [PMID: 26998001]
  74. Circulation. 2023 Dec 12;148(24):1958-1973 [PMID: 37937441]
  75. Hum Reprod. 2022 Jul 30;37(8):1835-1855 [PMID: 35728080]
  76. Fertil Steril. 2009 Aug;92(2):667-77 [PMID: 18710713]
  77. Int J Gynaecol Obstet. 2009 Jun;105(3):226-9 [PMID: 19345941]
  78. Endocr Connect. 2017 Oct;6(7):437-445 [PMID: 28739562]
  79. Endocr Pract. 2014 Mar;20(3):244-51 [PMID: 24246334]
  80. Eur Respir Rev. 2019 Nov 6;28(154): [PMID: 31694839]
  81. Cochrane Database Syst Rev. 2015 Oct 14;(10):CD011165 [PMID: 26465274]
  82. Nat Sci Sleep. 2018 Apr 04;10:105-110 [PMID: 29670412]
  83. Sleep Med. 2017 Aug;36:165-169 [PMID: 28599952]
  84. Med Clin North Am. 2008 Sep;92(5):1163-92, xi [PMID: 18721657]
  85. BMC Cardiovasc Disord. 2024 Apr 01;24(1):189 [PMID: 38561664]
  86. Ann Am Thorac Soc. 2013 Apr;10(2):115-20 [PMID: 23607839]
  87. Pharmaceuticals (Basel). 2023 Jan 28;16(2): [PMID: 37259345]
  88. Int J Clin Exp Med. 2013 Oct 25;6(10):880-9 [PMID: 24260593]
  89. Eur J Endocrinol. 2019 Apr;180(4):265-272 [PMID: 30763274]
  90. BMC Ophthalmol. 2018 Mar 2;18(1):66 [PMID: 29499674]
  91. J Clin Sleep Med. 2021 Oct 1;17(10):2041-2047 [PMID: 33983110]
  92. Sleep Breath. 2023 Oct;27(5):1733-1742 [PMID: 36609819]
  93. BMJ. 2003 Sep 6;327(7414):557-60 [PMID: 12958120]

MeSH Term

Female
Humans
Polycystic Ovary Syndrome
Sleep Apnea, Obstructive

Word Cloud

Created with Highcharts 10.0.0PCOSOSAHSwomenmetabolicsyndromemeta-analysismorbiditydifferenceseffectanalyzedsleepapnea-hypopneapatientsovarydiagnosedprevalenceindicatorsOSAHS-positiveOSAHS-negativeliteratureanalysiscomparisonvariablesunitscombinedmeansizesbasismodel50%criteriasubgroupsworseBackground:ObstructivecorrelateddeteriorationexperiencingpolycysticWomenexhibitheightenedaimsassessaffectedexaminemetabolism-relatedMethods:comprehensiveconductedutilizingdatabasesCNKIEMBASEPubMedWebScienceWanfangcarriedtermsclinicalcharacteristicssearchlanguageincludedEnglishChineseacquireddataemployingRevMan52Stata110ContinuousweightedWMDscontinuousdifferentstandardizedSMDsconjointperformedvalueusingeitherfixedrandom>Results:total21articlesmetinclusionstudyfindingsindicated208%foundcomorbidsubjectscategorizedvariousraceagediseaseseveritybodymassindexBMIdiagnosticresultsrevealedhighadditionparametersnotablysufferingcounterpartssolelyConclusion:currentindicateshigheramonglinkingstatusobesitypopulationConsequentlycliniciansadvisedprioritizedetectionmanagementSystematicReviewRegistration:https://wwwcrdyorkacuk/PROSPERO/#myprosperoPROSPEROidentifierCRD42024528264Polycysticobstructivesyndrome:updatedmetabolism

Similar Articles

Cited By